Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Prognostic Significance of the Polymorphisms in Thymidylate Synthase and Methylenetetrahydrofolate Reductase Gene in Lung Cancer

AKIRA TAKEHARA, KAZUYUKI KAWAKAMI, NAOHIRO OHTA, KAEKO OYAMA, YASUHIKO OTA, MAKOTO ODA and GO WATANABE
Anticancer Research November 2005, 25 (6C) 4455-4461;
AKIRA TAKEHARA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUYUKI KAWAKAMI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kawakami{at}med.kanazawa-u.ac.jp
NAOHIRO OHTA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAEKO OYAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUHIKO OTA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAKOTO ODA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GO WATANABE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 25 no. 6C 4455-4461
PMID 
16334126

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received March 9, 2005
  • Accepted June 29, 2005
  • Published online November 1, 2005.

Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. AKIRA TAKEHARA,
  2. KAZUYUKI KAWAKAMI,
  3. NAOHIRO OHTA,
  4. KAEKO OYAMA,
  5. YASUHIKO OTA,
  6. MAKOTO ODA and
  7. GO WATANABE
  1. Department of Surgery, Kanazawa University School of Medicine, Kanazawa 920-8641, Japan
  1. Correspondence to: Kazuyuki Kawakami, MD, Ph.D., Department of Surgery, Kanazawa University School of Medicine, 13-1 Takaramachi, Kanazawa 920-8641, Japan. Tel: +81-76-265-2355, Fax: +81-76-222-6833, e-mail: kawakami{at}med.kanazawa-u.ac.jp

Statistics from Altmetric.com

Cited By...

  • 14 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 25, Issue 6C
1 Nov 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic Significance of the Polymorphisms in Thymidylate Synthase and Methylenetetrahydrofolate Reductase Gene in Lung Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Prognostic Significance of the Polymorphisms in Thymidylate Synthase and Methylenetetrahydrofolate Reductase Gene in Lung Cancer
AKIRA TAKEHARA, KAZUYUKI KAWAKAMI, NAOHIRO OHTA, KAEKO OYAMA, YASUHIKO OTA, MAKOTO ODA, GO WATANABE
Anticancer Research Nov 2005, 25 (6C) 4455-4461;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Prognostic Significance of the Polymorphisms in Thymidylate Synthase and Methylenetetrahydrofolate Reductase Gene in Lung Cancer
AKIRA TAKEHARA, KAZUYUKI KAWAKAMI, NAOHIRO OHTA, KAEKO OYAMA, YASUHIKO OTA, MAKOTO ODA, GO WATANABE
Anticancer Research Nov 2005, 25 (6C) 4455-4461;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer
  • Google Scholar

More in this TOC Section

  • Clinical Outcomes and Prognostic Factors in Patients With Pelvic Sarcomas
  • The Association Between Longitudinal Changes in TRACP-5b and Bone Metastasis Progression During Osimertinib Therapy
  • Real-world Patterns and Trends of Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer: Insights from a Large Prospective German Cohort
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire